How Individual Genetic Test Disclosure May Affect Population Health

Abstract

Get full access to this article

View all access options for this article.

References

Loewenstein

Brennan

Volpp

. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298:2415–7.

Meigs

Shrader

Sullivan

. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359:2208–19.

Vassy

O’Brien

Waxler

. Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing. Med Decis Making. 2012;32:606–15.

Weinstein

. Testing four competing theories of health-protective behavior. Health Psychol. 1993;12:324–33.

Markowitz

Park

Delahanty

O’Brien

Grant

. Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes Care. 2011;34:568–73.

Fagerlin

Zikmund-Fischer

Ubel

. “If I’m better than average, then I’m ok?”: comparative information influences beliefs about risk and benefits. Patient Educ Couns. 2007;69:140–4.

Jackevicius

Mamdani

. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462–7.

Fagerlin

Dillard

Smith

. Women’s interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid. Breast Cancer Res Treat. 2011;127:681–8.